Information  X 
Enter a valid email address

Synairgen PLC Ord 1P (SNG)

Date Time Source Announcement
15 Feb 2021 7:00 am
RNS
Dosing commenced in US ACTIV-2 trial
  7:00 am
GNW
Synairgen announces that dosing has commenced with its inhaled interferon beta product in US Government-funded NIH ACTIV-2 trial in COVID-19 outpatients
25 Jan 2021 7:00 am
RNS
Inclusion in US ACTIV-2 trial
  7:00 am
GNW
Synairgen announces inclusion of its inhaled interferon beta treatment in US NIH ACTIV-2 trial in COVID-19 outpatients
20 Jan 2021 7:00 am
RNS
Home trial recruitment completed
  7:00 am
GNW
Synairgen announces completion of recruitment into its Phase II Home-Based COVID-19 study of inhaled interferon beta
13 Jan 2021 7:00 am
RNS
First Patient Dosing in Phase III SG018 Trial
  7:00 am
GNW
Synairgen announces commencement of dosing in its international Phase III study of inhaled interferon beta in hospitalised COVID-19 patients
06 Jan 2021 5:10 pm
RNS
Holding(s) in Company
05 Jan 2021 5:53 pm
RNS
Holding(s) in Company
18 Dec 2020 7:00 am
RNS
COVID-19 Clinical Programme Update
  7:00 am
GNW
COVID-19 Clinical Programme Update
10 Dec 2020 12:57 pm
RNS
Holding(s) in Company
13 Nov 2020 5:03 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Lancet Respiratory Medicine publishes Phase 2 data
10 Nov 2020 1:47 pm
RNS
Holding(s) in Company
04 Nov 2020 5:51 pm
RNS
Holding(s) in Company
03 Nov 2020 9:00 am
RNS
Holding(s) in Company
02 Nov 2020 12:20 pm
RNS
Result of General Meeting and Total Voting Rights
  7:00 am
RNS
Result of Open Offer
28 Oct 2020 11:20 am
RNS
Holding(s) in Company
27 Oct 2020 8:35 am
RNS
Holding(s) in Company
21 Oct 2020 9:45 am
RNS
Holding(s) in Company
  9:40 am
RNS
Holding(s) in Company
16 Oct 2020 3:10 pm
RNS
Exercise of Options and Total Voting Rights
15 Oct 2020 5:35 pm
RNS
Exercise of Options and Total Voting Rights
  1:51 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Results of Placing
14 Oct 2020 5:32 pm
RNS
Placing and Open Offer
12 Oct 2020 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
06 Oct 2020 8:55 am
RNS
Holding(s) in Company
02 Oct 2020 7:00 am
RNS
Appointment of Joint Broker
01 Oct 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:00 am
RNS
Price Monitoring Extension
29 Sep 2020 7:00 am
RNS
Clinigen signs MAP agreement with Synairgen
  7:00 am
RNS
Synairgen and Clinigen sign Managed Access Program
  7:00 am
RNS
Interim results for six months ended 30 June 2020
09 Sep 2020 7:00 am
RNS
Synairgen IP Update
08 Sep 2020 7:00 am
RNS
Positive interim analysis of SNG001 in COPD
07 Sep 2020 3:53 pm
RNS
Holding(s) in Company
03 Sep 2020 5:58 pm
RNS
Holding(s) in Company
01 Sep 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
24 Aug 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
21 Aug 2020 5:28 pm
RNS
Holding(s) in Company
13 Aug 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:57 am
RNS
Holding(s) in Company
10 Aug 2020 9:50 am
RNS
Holding(s) in Company
07 Aug 2020 8:22 am
RNS
Holding(s) in Company
05 Aug 2020 5:51 pm
RNS
Holding(s) in Company
31 Jul 2020 8:37 am
RNS
Holding(s) in Company
29 Jul 2020 4:43 pm
RNS
Holding(s) in Company
28 Jul 2020 3:13 pm
RNS
Holding(s) in Company
  9:01 am
RNS
Holding(s) in Company
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t